FDA Asked to Approve Test of Ovarian Cancers Likely to Respond to Zejula Maintenance Therapy
News
Myriad Genetics has filed a supplementary premarket approval (sPMA) application with the U.S. Food and Drug Administration (FDA) seeking approval of its myChoice CDx test to identify advanced ovarian cancer patients more likely ... Read more